(VIANEWS) - Nicolet Bankshares (NCBS), BancorpSouth (BXS), Sun Communities (SUI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Nicolet Bankshares (NCBS)
59% sales growth and 9.85% return on equity
Nicolet Bankshares, Inc. operates as the holding company for Nicolet National Bank that provides commercial and retail banking services for businesses and individuals.
Nicolet Bankshares's sales growth this year is expected to be 26.3% and 31.6% for next year.
Year-on-year quarterly revenue growth declined by 10.5%, now sitting on 198.79M for the twelve trailing months.
Volume
Today's last reported volume for Nicolet Bankshares is 19193 which is 69.15% below its average volume of 62229.
Nicolet Bankshares's sales growth for the next quarter is 59%. The company's growth estimates for the current quarter and the next is a negative 28.7% and negative -14.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.85%.
Volatility
Nicolet Bankshares's last day, last week, and last month's current intraday variation average was 0.18%, 1.69%, and 1.50%, respectively.
Nicolet Bankshares's highest amplitude of average volatility was 2.94% (day), 4.20% (last week), and 3.38% (last month), respectively.
Nicolet Bankshares's Stock Yearly Top and Bottom Value
Nicolet Bankshares's stock is valued at $87.20 at 10:22 EST, below its 52-week high of $87.75 and way above its 52-week low of $66.16.
Nicolet Bankshares's Moving Average
Nicolet Bankshares's worth is way above its 50-day moving average of $75.41 and way higher than its 200-day moving average of $76.06.2. BancorpSouth (BXS)
57.4% sales growth and 10.33% return on equity
BancorpSouth Bank provides commercial banking and financial services to individuals and small-to-medium size businesses.
BancorpSouth's sales growth this year is anticipated to be 16.8% and 47.4% for next year.
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 1.03B for the twelve trailing months.
Volume
Today's last reported volume for BancorpSouth is 19263400 which is 1096.25% above its average volume of 1610320.
BancorpSouth's sales growth for the next quarter is 57.4%. The company's growth estimates for the ongoing quarter and the next is a negative 7.2% and negative -155.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.33%.
Volatility
BancorpSouth's last day, last week, and last month's current intraday variation average was 0.43%, 0.67%, and 1.72%, respectively.
BancorpSouth's highest amplitude of average volatility was 1.13% (day), 1.82% (last week), and 2.93% (last month), respectively.
BancorpSouth's Stock Yearly Top and Bottom Value
BancorpSouth's stock is valued at $28.76 at 10:22 EST, way under its 52-week high of $35.59 and way higher than its 52-week low of $24.87.
BancorpSouth's Moving Average
BancorpSouth's worth is under its 50-day moving average of $30.17 and below its 200-day moving average of $29.14.3. Sun Communities (SUI)
44.6% sales growth and 4.45% return on equity
Sun Communities, Inc. is a REIT that, as of September 30, 2020, owned, operated, or had an interest in a portfolio of 432 communities comprising nearly 146,000 developed sites in 32 states and Ontario, Canada.
Sun Communities's sales growth this year is expected to be 81.4% and a negative 3.5% for next year.
Year-on-year quarterly revenue growth grew by 99.2%, now sitting on 1.81B for the twelve trailing months.
Volume
Today's last reported volume for Sun Communities is 467211 which is 28.39% below its average volume of 652438.
Sun Communities's sales growth for the next quarter is 44.6%. The company's growth estimates for the current quarter and the next is 25.6% and negative -12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.45%.
Volatility
Sun Communities's last day, last week, and last month's current intraday variation average was 0.82%, 1.50%, and 0.86%, respectively.
Sun Communities's highest amplitude of average volatility was 1.70% (day), 2.88% (last week), and 1.95% (last month), respectively.
Sun Communities's Stock Yearly Top and Bottom Value
Sun Communities's stock is valued at $207.64 at 10:22 EST, under its 52-week high of $209.98 and way above its 52-week low of $137.43.
Sun Communities's Moving Average
Sun Communities's value is above its 50-day moving average of $195.34 and way higher than its 200-day moving average of $180.63.4. Organogenesis Holdings (ORGO)
19.7% sales growth and 48.88% return on equity
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.
Organogenesis Holdings 's sales growth this year is expected to be 37.1% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 446.31M for the twelve trailing months.
Volume
Today's last reported volume for Organogenesis Holdings is 503110 which is 53.13% below its average volume of 1073510.
Organogenesis Holdings 's sales growth for the next quarter is 19.7%. The company's growth estimates for the current quarter and the next is a negative 46.7% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.88%.
Volatility
Organogenesis Holdings 's last day, last week, and last month's current intraday variation average was 2.17%, 3.27%, and 2.65%, respectively.
Organogenesis Holdings 's highest amplitude of average volatility was 6.67% (day), 6.21% (last week), and 5.65% (last month), respectively.
Organogenesis Holdings 's Stock Yearly Top and Bottom Value
Organogenesis Holdings 's stock is valued at $9.27 at 10:22 EST, way below its 52-week high of $24.34 and way higher than its 52-week low of $6.64.
Organogenesis Holdings 's Moving Average
Organogenesis Holdings 's worth is way under its 50-day moving average of $10.40 and way below its 200-day moving average of $15.27.5. Discovery (DISCK)
12.4% sales growth and 11.2% return on equity
Discovery, Inc., a media company, provides content across various distribution platforms in approximately 50 languages worldwide.
Discovery's sales growth this year is expected to be 13.6% and 4.6% for next year.
Year-on-year quarterly revenue growth grew by 23%, now sitting on 11.89B for the twelve trailing months.
Volume
Today's last reported volume for Discovery is 3291100 which is 7.15% below its average volume of 3544650.
Discovery's sales growth for the next quarter is 12.4%. The company's growth estimates for the ongoing quarter and the next is 5.3% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.2%.
Volatility
Discovery's last day, last week, and last month's current intraday variation average was 0.76%, 1.67%, and 2.22%, respectively.
Discovery's highest amplitude of average volatility was 4.77% (day), 3.83% (last week), and 4.37% (last month), respectively.
Discovery's Stock Yearly Top and Bottom Value
Discovery's stock is valued at $22.02 at 10:22 EST, way below its 52-week high of $66.70 and above its 52-week low of $20.86.
Discovery's Moving Average
Discovery's worth is under its 50-day moving average of $24.18 and way under its 200-day moving average of $29.88.6. Ambev (ABEV)
11.9% sales growth and 17.02% return on equity
Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas.
Ambev's sales growth this year is anticipated to be 15.4% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 32%, now sitting on 62.42B for the twelve trailing months.
Volume
Today's last reported volume for Ambev is 12061000 which is 47.23% below its average volume of 22858100.
Ambev's sales growth for the next quarter is 11.9%. The company's growth estimates for the present quarter and the next is a negative 0% and negative -50%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.02%.
Volatility
Ambev's last day, last week, and last month's current intraday variation average was 0.37%, 1.91%, and 1.20%, respectively.
Ambev's highest amplitude of average volatility was 2.21% (day), 1.55% (last week), and 1.95% (last month), respectively.
Ambev's Stock Yearly Top and Bottom Value
Ambev's stock is valued at $2.71 at 10:22 EST, way under its 52-week high of $3.95 and way higher than its 52-week low of $2.38.